Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine
Timo Vesikari(Tampere University), Penny M. Heaton(Johnson & Johnson (Singapore))
Cited by 1,879
Related Papers
Successes and Opportunities during the Pandemic: Reflections and Revelations from a Vaccine Development Perspective
|Clinical Pharmacology & Therapeutics|2023|3